Developer docs
API playgroundTry for free, no card

Search company profiles

Unipharm

Full company profile

uuid0009tdz

Namestring
Unipharm
Legal namestring
UNIPHARM, INC.
Websiteurl
unipharmus.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Unipharm is a privately held international pharmaceuticals company founded in 1992 and headquartered in New York, USA. The company manufactures and markets over-the-counter (OTC) drugs and nutritional supplements, primarily serving mass-market consumers across Eurasian markets. Its product portfolio includes MELAXEN (melatonin-based sleep aid), DETRIMAX (Vitamin D3 supplements in adult and pediatric formulations), LACTOBALANCE (multiprobiotic supplements with 9 bacterial strains delivering 3 billion CFU per capsule), GRIPPEX (paracetamol/pseudoephedrine/dextromethorphan cold and flu medication), and additional supplement lines (MULTIMAX, ARTHRON, VITRUM) addressing joint, vision, active lifestyle, beauty, and children's nutrition use-cases. Manufacturing is carried out in established facilities in the United States and European Union under GMP guidelines, with raw materials sourced from GMP-certified vendors. The company is FDA-registered and operates quality control processes including raw material testing, microbiological analysis, physical and quantitative analysis, and government-authority testing in each target market.

The business model is a consumer goods distribution play rather than a drug development enterprise. Unipharm monetizes through one-time product sales of its branded OTC and supplement lines via retail and pharmacy channels across nine countries (USA, Ireland, Poland, Ukraine, Georgia, Kazakhstan, Moldova, Azerbaijan, and Uzbekistan), supported by a wholly-owned subsidiary and representative office structure. Its customer segmentation is horizontal, with general consumer health as the primary segment and secondary use-case segments spanning children's nutrition, active lifestyle, beauty/wellness, joint/bone support, vision health, and seasonal illness prevention. Pricing is not publicly disclosed, and the company relies on its corporate website plus country-specific local sites (e.g., unipharm.pl, unipharm.ua, unipharm.ge, unipharm.kz) as the primary marketing and customer-interaction channel. Distribution in the US is supported by a partnership with Ameripharma Labs.

From a corporate-structure perspective, Unipharm, Inc. is the US parent, with Unipharm Laboratories Limited (Dublin, Ireland) serving as the European operating entity and Unipharm Sp. z o.o. (Warsaw, Poland) handling Polish operations; the remaining countries are served via wholly-owned representative offices. The company has no disclosed institutional investors, no funding rounds, and no M&A activity in the source data, consistent with a founder-driven, cash-flow-funded private business. Headcount is reported in the 101-250 range, and the firm has maintained continuous operations for over 25 years with an emphasis on brand-led market leadership in its Eurasian core markets and a documented charitable-donation program spanning NGOs in multiple geographies.

Short descriptiontext

Unipharm is a privately held New York-based pharmaceuticals company that manufactures and distributes OTC drugs and nutritional supplements (MELAXEN, DETRIMAX, LACTOBALANCE, GRIPPEX) through retail and pharmacy channels across nine countries, primarily serving Eurasian consumer health markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
OTC pharmaceuticals, nutritional supplements, vitamin D supplements, probiotic supplements, cold and flu remedies
Industry4 codes
PRIMARYCRADAMAJ
Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAG
Sleep, Stress & Mood Support
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIAJAC
OTC & Consumer Health Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
OTC Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1OTC Drug Sales
TypeOne Time License
Description

Sale of over-the-counter medications including Grippex (cold/flu relief) and Melaxen (melatonin sleep aid). Products are sold through retail and pharmacy channels globally.

unipharmus.com
2Nutritional Supplement Sales
TypeOne Time License
Description

Sale of vitamin and mineral nutritional supplements including Detrimax (Vitamin D), Lactobalance (probiotics), and Multimax product lines for various health needs.

unipharmus.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1MELAXEN®
Description

Melatonin supplement for sleep support, 3mg tablets

unipharmus.com
+8 more records
Core offering1 text field

Unipharm manufactures and markets over-the-counter (OTC) drugs and nutritional supplements sold through retail and pharmacy channels. Core offerings include melatonin-based sleep aids (MELAXEN), Vitamin D3 supplements (DETRIMAX), multiprobiotic supplements (LACTOBALANCE), and cold/flu relief medication (GRIPPEX). Products are manufactured in the USA and EU under GMP guidelines and distributed across Eurasian markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 37% decline in daily melatonin output between ages 20-70 addressed by MELAXEN
+1 more record
Product overview1 text field

Unipharm is a pharmaceutical and nutritional supplement company offering a portfolio of over-the-counter products. The core product lineup includes: MELAXEN® 3 mg (melatonin-based sleep supplement), DETRIMAX® and DETRIMAX® BABY (Vitamin D3 supplements for adults and infants), LACTOBALANCE® and LACTOBALANCE® KIDS (multiprobiotic supplements with 9 probiotic strains for adults and children), and GRIPPEX® (cold and flu relief medication). Products are manufactured in the USA and European Union following GMP guidelines, with the company being FDA registered.

Product and service6 records
1MELAXEN® 3 mg
CategoryOTC Pharmaceuticals
Description

Sleep aid supplement containing melatonin (3 mg tablets), a hormone that regulates the normal sleep/wake cycle. Supports healthy sleep cycles in individuals suffering from occasional sleeplessness, particularly when adjusting to staggered work cycles or jet lag. Marketed to adult consumers.

2DETRIMAX®
CategoryNutritional Supplements
Description

Vitamin D3 (cholecalciferol) supplement available in tablet form with dosages of 1000 IU, 2000 IU, 4000 IU, and 5000 IU. Supports bone, dental, and immune health in adults.

3DETRIMAX® BABY
CategoryNutritional Supplements
Description

Vitamin D3 supplement specifically formulated for infants and young children. Contains 200 IU per drop in a 30 ml bottle with pump dispenser. Supports bone and dental tissue development and immune function.

4LACTOBALANCE®
CategoryNutritional Supplements
Description

Multiprobiotic supplement containing a balanced combination of 9 strains of probiotic microorganisms (bifidobacteria and lactobacilli) producing at least 3 billion CFU per capsule. Strains are resistant to gastric juice, digestive enzymes, and bile acids with high adhesion to intestinal mucosa. Supports restoration of normal intestinal microflora and immune function.

5LACTOBALANCE® KIDS
CategoryNutritional Supplements
Description

Children's multiprobiotic supplement with 9 probiotic strains producing 3 billion CFU per capsule, produced in Japan. Formulated to restore and normalize intestinal microflora in children from 3 years of age. Available as 14 chewable tablets with vanilla taste.

6GRIPPEX®
CategoryOTC Pharmaceuticals
Description

Over-the-counter cold and flu medication combining 325 mg paracetamol, 30 mg pseudoephedrine, and 10 mg dextromethorphan. Temporarily relieves symptoms of the common cold including runny nose, sneezing, cough, headache, nasal congestion, and fever. For adults and children over 12 years old.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Ameripharma Labs is shown as a partner/distributor with logo displayed on Unipharm website. Ameripharma Labs logo is linked from the main navigation.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pharmstandard is the largest Russian pharmaceutical company by retail sales, with a portfolio of OTC drugs, pharmaceuticals, and supplements sold across CIS markets. It is the closest direct peer to Unipharm in terms of product categories (OTC, vitamins, probiotics), Eurasian geographic focus, and brand-driven distribution model.

TypeDirect peer
Description

OTCPharm is a leading Russian OTC distributor and brand owner, owned by Pharmstandard, specializing in cold/flu, vitamins, and consumer health products across Russia and CIS. Comparable to Unipharm in product mix, distribution channels, and regional concentration.

TypeDirect peer
Description

Evalar is one of the largest Russian manufacturers of dietary supplements and OTC natural health products, with vertically integrated cultivation, manufacturing, and pharmacy distribution. Directly comparable to Unipharm in probiotic, vitamin, and supplement categories and in Eurasian market positioning.

4Natrol
TypeDirect peer
Description

Natrol is a US-based dietary supplement manufacturer best known for its melatonin sleep products and broader vitamin/supplement portfolio, now part of Aurobindo Pharma. Highly comparable to Unipharm's MELAXEN sleep brand and LACTOBALANCE probiotic positioning, but operating primarily in the US retail channel.

5Bayer Consumer Health
TypeBroad incumbent
Description

Bayer Consumer Health operates a global OTC and supplement portfolio including brands like Berocca, Elevit, and Canesten. Overlaps with Unipharm's vitamins, cold/flu, and general wellness categories but at significantly larger scale, broader geographic reach, and stronger marketing budgets.

TypeBroad incumbent
Description

Perrigo is a global OTC consumer healthcare and generic pharmaceutical company with deep presence in store-brand and branded OTC categories. Comparable to Unipharm in OTC manufacturing capabilities and retail distribution, but operating at substantially larger scale across the US, Europe, and emerging markets.

TypeBroad incumbent
Description

Sanofi's Consumer Healthcare division markets global OTC brands including sleep, vitamin, and cold/flu products across all major geographies. Comparable to Unipharm in core OTC categories but competes at global scale with vastly greater R&D and marketing resources.

TypeBroad incumbent
Description

Church & Dwight owns a portfolio of consumer health brands including vitamin and supplement lines (e.g., Vitafusion, First Response). Overlaps with Unipharm in vitamins and consumer health OTC, with broader US mass-market distribution and significantly larger marketing spend.

TypeDirect peer
Description

NOW Foods is a US-based family-owned manufacturer and distributor of dietary supplements, vitamins, and natural health products including melatonin and probiotic lines. Comparable to Unipharm in product categories and GMP manufacturing, but with stronger US direct-to-consumer and e-commerce presence.

TypeBroad incumbent
Description

Haleon (formerly GSK Consumer Healthcare) is a global consumer health company with major OTC and supplement brands across pain relief, vitamins, and oral health. Operates at global scale in categories overlapping with Unipharm's MELAXEN, DETRIMAX, and GRIPPEX portfolios.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Unipharm

OTC Pharmaceuticalsunipharmus.com

Unipharm is a privately held New York-based pharmaceuticals company that manufactures and distributes OTC drugs and nutritional supplements (MELAXEN, DETRIMAX, LACTOBALANCE, GRIPPEX) through retail and pharmacy channels across nine countries, primarily serving Eurasian consumer health markets.

What Unipharm does

Unipharm is a privately held international pharmaceuticals company founded in 1992 and headquartered in New York, USA. The company manufactures and markets over-the-counter (OTC) drugs and nutritional supplements, primarily serving mass-market consumers across Eurasian markets. Its product portfolio includes MELAXEN (melatonin-based sleep aid), DETRIMAX (Vitamin D3 supplements in adult and pediatric formulations), LACTOBALANCE (multiprobiotic supplements with 9 bacterial strains delivering 3 billion CFU per capsule), GRIPPEX (paracetamol/pseudoephedrine/dextromethorphan cold and flu medication), and additional supplement lines (MULTIMAX, ARTHRON, VITRUM) addressing joint, vision, active lifestyle, beauty, and children's nutrition use-cases. Manufacturing is carried out in established facilities in the United States and European Union under GMP guidelines, with raw materials sourced from GMP-certified vendors. The company is FDA-registered and operates quality control processes including raw material testing, microbiological analysis, physical and quantitative analysis, and government-authority testing in each target market.

The business model is a consumer goods distribution play rather than a drug development enterprise. Unipharm monetizes through one-time product sales of its branded OTC and supplement lines via retail and pharmacy channels across nine countries (USA, Ireland, Poland, Ukraine, Georgia, Kazakhstan, Moldova, Azerbaijan, and Uzbekistan), supported by a wholly-owned subsidiary and representative office structure. Its customer segmentation is horizontal, with general consumer health as the primary segment and secondary use-case segments spanning children's nutrition, active lifestyle, beauty/wellness, joint/bone support, vision health, and seasonal illness prevention. Pricing is not publicly disclosed, and the company relies on its corporate website plus country-specific local sites (e.g., unipharm.pl, unipharm.ua, unipharm.ge, unipharm.kz) as the primary marketing and customer-interaction channel. Distribution in the US is supported by a partnership with Ameripharma Labs.

From a corporate-structure perspective, Unipharm, Inc. is the US parent, with Unipharm Laboratories Limited (Dublin, Ireland) serving as the European operating entity and Unipharm Sp. z o.o. (Warsaw, Poland) handling Polish operations; the remaining countries are served via wholly-owned representative offices. The company has no disclosed institutional investors, no funding rounds, and no M&A activity in the source data, consistent with a founder-driven, cash-flow-funded private business. Headcount is reported in the 101-250 range, and the firm has maintained continuous operations for over 25 years with an emphasis on brand-led market leadership in its Eurasian core markets and a documented charitable-donation program spanning NGOs in multiple geographies.

Unipharm firmographics

Firmographics
Name
Unipharm
Legal name
UNIPHARM, INC.
Website
https://unipharmus.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
101–250 employees
Short description
Unipharm is a privately held New York-based pharmaceuticals company that manufactures and distributes OTC drugs and nutritional supplements (MELAXEN, DETRIMAX, LACTOBALANCE, GRIPPEX) through retail and pharmacy channels across nine countries, primarily serving Eurasian consumer health markets.
Ownership category
akta.pro rank

Unipharm industry classification

Industry
Product category
OTC Pharmaceuticals
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAMAJ
Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAG
Sleep, Stress & Mood Support
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIAJAC
OTC & Consumer Health Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • OTC pharmaceuticals
  • Nutritional supplements
  • Vitamin D supplements
  • Probiotic supplements
  • Cold and flu remedies

Where Unipharm is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices9 records

Markets served

Unipharm business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. OTC Drug Sales: Sale of over-the-counter medications including Grippex (cold/flu relief) and Melaxen (melatonin sleep aid). Products are sold through retail and pharmacy channels globally.
  2. Nutritional Supplement Sales: Sale of vitamin and mineral nutritional supplements including Detrimax (Vitamin D), Lactobalance (probiotics), and Multimax product lines for various health needs.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Unipharm product offering

Product offering

Core offering

Unipharm manufactures and markets over-the-counter (OTC) drugs and nutritional supplements sold through retail and pharmacy channels. Core offerings include melatonin-based sleep aids (MELAXEN), Vitamin D3 supplements (DETRIMAX), multiprobiotic supplements (LACTOBALANCE), and cold/flu relief medication (GRIPPEX). Products are manufactured in the USA and EU under GMP guidelines and distributed across Eurasian markets.

Product overview

Unipharm is a pharmaceutical and nutritional supplement company offering a portfolio of over-the-counter products. The core product lineup includes: MELAXEN® 3 mg (melatonin-based sleep supplement), DETRIMAX® and DETRIMAX® BABY (Vitamin D3 supplements for adults and infants), LACTOBALANCE® and LACTOBALANCE® KIDS (multiprobiotic supplements with 9 probiotic strains for adults and children), and GRIPPEX® (cold and flu relief medication). Products are manufactured in the USA and European Union following GMP guidelines, with the company being FDA registered.

Differentiator

Problem solved

Functional benefit

Brands

  • MELAXEN®: Melatonin supplement for sleep support, 3mg tablets
  • DETRIMAX®
  • DETRIMAX® BABY
  • LACTOBALANCE®
  • LACTOBALANCE® KIDS
  • GRIPPEX®
  • MULTIMAX®
  • ARTHRON®
  • VITRUM®

Products and services

  • MELAXEN® 3 mg Sleep aid supplement containing melatonin (3 mg tablets), a hormone that regulates the normal sleep/wake cycle. Supports healthy sleep cycles in individuals suffering from occasional sleeplessness, particularly when adjusting to staggered work cycles or jet lag. Marketed to adult consumers.
  • DETRIMAX® Vitamin D3 (cholecalciferol) supplement available in tablet form with dosages of 1000 IU, 2000 IU, 4000 IU, and 5000 IU. Supports bone, dental, and immune health in adults.
  • DETRIMAX® BABY Vitamin D3 supplement specifically formulated for infants and young children. Contains 200 IU per drop in a 30 ml bottle with pump dispenser. Supports bone and dental tissue development and immune function.
  • LACTOBALANCE® Multiprobiotic supplement containing a balanced combination of 9 strains of probiotic microorganisms (bifidobacteria and lactobacilli) producing at least 3 billion CFU per capsule. Strains are resistant to gastric juice, digestive enzymes, and bile acids with high adhesion to intestinal mucosa. Supports restoration of normal intestinal microflora and immune function.
  • LACTOBALANCE® KIDS Children's multiprobiotic supplement with 9 probiotic strains producing 3 billion CFU per capsule, produced in Japan. Formulated to restore and normalize intestinal microflora in children from 3 years of age. Available as 14 chewable tablets with vanilla taste.
  • GRIPPEX® Over-the-counter cold and flu medication combining 325 mg paracetamol, 30 mg pseudoephedrine, and 10 mg dextromethorphan. Temporarily relieves symptoms of the common cold including runny nose, sneezing, cough, headache, nasal congestion, and fever. For adults and children over 12 years old.

Quantifiable outcome

  • 37% decline in daily melatonin output between ages 20-70 addressed by MELAXEN
  • +1 more outcomes

Companies that use Unipharm

Customer profile

Named customers5 records

Segments7 records

Ideal customer profiles3 records

Unipharm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Unipharm partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AmeripharmaminorOthersAmeripharma Labs is shown as a partner/distributor with logo displayed on Unipharm website. Ameripharma Labs logo is linked from the main navigation.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Unipharm competitors and assessment

Company assessment

Direct peers

  • Pharmstandard: Pharmstandard is the largest Russian pharmaceutical company by retail sales, with a portfolio of OTC drugs, pharmaceuticals, and supplements sold across CIS markets. It is the closest direct peer to Unipharm in terms of product categories (OTC, vitamins, probiotics), Eurasian geographic focus, and brand-driven distribution model.
  • OTCPharm: OTCPharm is a leading Russian OTC distributor and brand owner, owned by Pharmstandard, specializing in cold/flu, vitamins, and consumer health products across Russia and CIS. Comparable to Unipharm in product mix, distribution channels, and regional concentration.
  • Evalar: Evalar is one of the largest Russian manufacturers of dietary supplements and OTC natural health products, with vertically integrated cultivation, manufacturing, and pharmacy distribution. Directly comparable to Unipharm in probiotic, vitamin, and supplement categories and in Eurasian market positioning.
  • Natrol: Natrol is a US-based dietary supplement manufacturer best known for its melatonin sleep products and broader vitamin/supplement portfolio, now part of Aurobindo Pharma. Highly comparable to Unipharm's MELAXEN sleep brand and LACTOBALANCE probiotic positioning, but operating primarily in the US retail channel.
  • NOW Foods: NOW Foods is a US-based family-owned manufacturer and distributor of dietary supplements, vitamins, and natural health products including melatonin and probiotic lines. Comparable to Unipharm in product categories and GMP manufacturing, but with stronger US direct-to-consumer and e-commerce presence.

Broad incumbents

  • Bayer Consumer Health: Bayer Consumer Health operates a global OTC and supplement portfolio including brands like Berocca, Elevit, and Canesten. Overlaps with Unipharm's vitamins, cold/flu, and general wellness categories but at significantly larger scale, broader geographic reach, and stronger marketing budgets.
  • Perrigo Company: Perrigo is a global OTC consumer healthcare and generic pharmaceutical company with deep presence in store-brand and branded OTC categories. Comparable to Unipharm in OTC manufacturing capabilities and retail distribution, but operating at substantially larger scale across the US, Europe, and emerging markets.
  • Sanofi Consumer Healthcare: Sanofi's Consumer Healthcare division markets global OTC brands including sleep, vitamin, and cold/flu products across all major geographies. Comparable to Unipharm in core OTC categories but competes at global scale with vastly greater R&D and marketing resources.
  • Church & Dwight: Church & Dwight owns a portfolio of consumer health brands including vitamin and supplement lines (e.g., Vitafusion, First Response). Overlaps with Unipharm in vitamins and consumer health OTC, with broader US mass-market distribution and significantly larger marketing spend.
  • Haleon: Haleon (formerly GSK Consumer Healthcare) is a global consumer health company with major OTC and supplement brands across pain relief, vitamins, and oral health. Operates at global scale in categories overlapping with Unipharm's MELAXEN, DETRIMAX, and GRIPPEX portfolios.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Unipharm social profiles

Digital presence

Unipharm compliance and trust

Trust signal

Compliance2 records

Unipharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Unipharm leadership team

Management profile

Number of profiles

Unipharm subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Unipharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Unipharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unipharm

What does Unipharm do?

Unipharm manufactures and markets over-the-counter (OTC) drugs and nutritional supplements sold through retail and pharmacy channels. Core offerings include melatonin-based sleep aids (MELAXEN), Vitamin D3 supplements (DETRIMAX), multiprobiotic supplements (LACTOBALANCE), and cold/flu relief medication (GRIPPEX). Products are manufactured in the USA and EU under GMP guidelines and distributed across Eurasian markets.

Is Unipharm a public or private company?

Unipharm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Unipharm founded?

Unipharm was founded in 1992. It employs 101 to 250 people.

Where is Unipharm based?

Unipharm is headquartered in New York, United States, in the North America region.

How does Unipharm make money?

Two revenue lines are on record. OTC Drug Sales are the primary driver. The others are nutritional Supplement Sales.

Who are Unipharm's main competitors?

Direct peers on record are Pharmstandard, OTCPharm, Evalar, Natrol and NOW Foods. Broad incumbents are Bayer Consumer Health, Perrigo Company, Sanofi Consumer Healthcare, Church & Dwight and Haleon.

Does Unipharm have an API?

No public API is recorded for Unipharm.

What industry is Unipharm in?

Unipharm's product category is OTC Pharmaceuticals. Its primary akta.pro industry code is CRADAMAJ, Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief), with a secondary code of CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief). Its NAICS code is 424210 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales